Cell penetrating recombinant Foxp3 protein enhances Treg function and ameliorates arthritis - PubMed (original) (raw)
Cell penetrating recombinant Foxp3 protein enhances Treg function and ameliorates arthritis
Kentaro Yomogida et al. Biochem Biophys Res Commun. 2013.
Abstract
Foxp3 is the master transcription factor for T regulatory (Treg) cell differentiation and function. This study aimed to test the therapeutic potential of cell penetrating recombinant Foxp3 protein in arthritis. Recombinant Foxp3 protein was fused to a cell penetrating polyarginine (Foxp3-11R) tag to facilitate intracellular transduction. In vitro Foxp3-11R treated CD4(+) T cells showed a 50% increase in suppressive function compared with control protein treated cells. Severity of arthritis in Foxp3-11R treated mice was significantly reduced compared with those treated with a control protein. CD4(+) T cells of lymph nodes and spleen from Foxp3-11R treated mice showed increased levels of Foxp3 expression compared with those of a control protein treated. These results demonstrated that Foxp3-11R can enhance T cell suppressive function and ameliorate experimental arthritis and suggest that cell penetrating recombinant Foxp3 is a potentially useful agent in therapy of arthritis.
Published by Elsevier Inc.
Conflict of interest statement
Competing Interests
SW, BB, CA, TC, BM and YZ are employees of VivoScript, Inc.
Figures
Figure 1. Generation of cell-permeable Foxp3-11R
(A) A schematic presentation of the Foxp3 fusion protein. (B) SKG mouse splenocytes were incubated with 10 μg/ml of Foxp3-11R, ASCL1-11R or culture medium in anti-CD3/CD28 coated plates for 120 hours, and Foxp3 was stained intracellularly. Mean fluorescence of Foxp3 was compared in the three treatment group. Data are representative of three independent experiments and mean ± SD (n=3). *p<0.05. (C) Splenocytes were treated as in (B) and stained with Annexin V and propidium iodide (PI). Figure shows CD4+ T cells stained by Annexin V (pooled data of three experiments, n=6 in each group).
Figure 2. Foxp3-11R treatment did not upregulate CD25, but induced Treg-like cells
(A) SKG mouse splenocytes were incubated with 10 μg/ml of Foxp3-11R, ASCL1-11R or culture medium in anti-CD3/CD28 coated plates for 120 hours, and CD25 on cell surface was stained. (B) Suppressor cells (sup) were prepared by incubating SKG mouse splenocytes with 40 μg/ml of Foxp3-11R, ASCL-11R, or culture medium for 1 hour and washed twice. As responder cells (res), SKG mouse splenocytes were stained with CFSE. Suppressor cells and responder cells were mixed at various ratios. Data are representative of three independent experiments.
Figure 3. Foxp3-11R prevented progression of arthritis in SKG mice
(A) Seven days after arthritis induction, SKG mice were treated with Foxp3-11R or ASCL1-11R for 7 days. Fourteen days after final treatment, splenocytes were harvested and Foxp3 was stained intracellularly. Data are CD4 T cell gated and mean ± SD (n=4). *p<0.05 (B) Severity of arthritis was monitored daily after the above treatment (n=10 in each group). (p=0.78 at week 4, p=0.02 at week 6 and p=0.033 at week 8, pooled data of two experiments).
Similar articles
- Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ T cells.
Polanczyk MJ, Walker E, Haley D, Guerrouahen BS, Akporiaye ET. Polanczyk MJ, et al. J Transl Med. 2019 Jul 9;17(1):219. doi: 10.1186/s12967-019-1967-3. J Transl Med. 2019. PMID: 31288845 Free PMC article. - CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
Ko HJ, Cho ML, Lee SY, Oh HJ, Heo YJ, Moon YM, Kang CM, Kwok SK, Ju JH, Park SH, Park KS, Kim HY. Ko HJ, et al. J Autoimmun. 2010 Mar;34(2):111-20. doi: 10.1016/j.jaut.2009.07.006. Epub 2009 Aug 8. J Autoimmun. 2010. PMID: 19665867 - IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM. Berretta F, et al. J Immunol. 2011 Apr 15;186(8):4862-71. doi: 10.4049/jimmunol.1003777. Epub 2011 Mar 9. J Immunol. 2011. PMID: 21389253 - Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis.
Fischer R, Proske M, Duffey M, Stangl H, Martinez GF, Peters N, Kraske A, Straub RH, Bethea JR, Kontermann RE, Pfizenmaier K. Fischer R, et al. Arthritis Rheumatol. 2018 May;70(5):722-735. doi: 10.1002/art.40413. Epub 2018 Mar 11. Arthritis Rheumatol. 2018. PMID: 29342501 - The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.
Zhang L, Zhao Y. Zhang L, et al. J Cell Physiol. 2007 Jun;211(3):590-7. doi: 10.1002/jcp.21001. J Cell Physiol. 2007. PMID: 17311282 Review.
Cited by
- Cell-penetrable mouse forkhead box protein 3 alleviates experimental arthritis in mice by up-regulating regulatory T cells.
Liu X, Ji B, Sun M, Wu W, Huang L, Sun A, Zong Y, Xia S, Shi L, Qian H, Xu W, Shao Q. Liu X, et al. Clin Exp Immunol. 2015 Jul;181(1):87-99. doi: 10.1111/cei.12630. Epub 2015 May 10. Clin Exp Immunol. 2015. PMID: 25809415 Free PMC article. - Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C, Radichev IA, Ellefson J, Williams M, Savinov AY. Amatya C, et al. Mol Ther. 2018 Jan 3;26(1):184-198. doi: 10.1016/j.ymthe.2017.08.014. Epub 2017 Sep 7. Mol Ther. 2018. PMID: 28988715 Free PMC article. - Regeneration of hyaline-like cartilage in situ with SOX9 stimulation of bone marrow-derived mesenchymal stem cells.
Zhang X, Wu S, Naccarato T, Prakash-Damani M, Chou Y, Chu CQ, Zhu Y. Zhang X, et al. PLoS One. 2017 Jun 30;12(6):e0180138. doi: 10.1371/journal.pone.0180138. eCollection 2017. PLoS One. 2017. PMID: 28666028 Free PMC article. - Delivery of transcription factors as modulators of cell differentiation.
Rilo-Alvarez H, Ledo AM, Vidal A, Garcia-Fuentes M. Rilo-Alvarez H, et al. Drug Deliv Transl Res. 2021 Apr;11(2):426-444. doi: 10.1007/s13346-021-00931-8. Epub 2021 Feb 20. Drug Deliv Transl Res. 2021. PMID: 33611769 Review.
References
- Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061. - PubMed
- Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science. 2007;317:627–629. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials